These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38144003)

  • 1. Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis.
    Chegeni M; Nili S; Darabi M; Gheysvandi E; Zahedi R; Sharifian E; Shoraka HR; Rostamkhani M; Gheshlaghi LA
    J Educ Health Promot; 2023; 12():356. PubMed ID: 38144003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis.
    Tabaeian SP; Rezapour A; Azari S; Martini M; Saran M; Behzadifar M; Shahabi S; Sayyad A; Tahernejad A; Bragazzi NL; Ehsanzadeh SJ; Behzadifar M
    J Clin Exp Hepatol; 2024; 14(1):101209. PubMed ID: 38076354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis.
    Alenezi YM; Harris R; Morling J; Card T
    Cureus; 2023 Jun; 15(6):e40308. PubMed ID: 37448425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis.
    Hassanipour S; Amini-Salehi E; Joukar F; Khosousi MJ; Pourtaghi F; Ansar MM; Mahdavi-Roshan M; Heidarzad F; Rashidi-Mojdehi G; Abdzadeh E; Vakilpour A; Mansour-Ghanaei F
    Iran J Public Health; 2023 Aug; 52(8):1600-1612. PubMed ID: 37744533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
    Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
    J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis.
    Virk GS; Vajje J; Virk NK; Mannam R; Rehman W; Ghobriel NG; Mian IU; Usama M
    Cureus; 2023 Aug; 15(8):e44413. PubMed ID: 37791219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
    Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
    Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.
    Shalimar ; Elhence A; Bansal B; Gupta H; Anand A; Singh TP; Goel A
    J Clin Exp Hepatol; 2022; 12(3):818-829. PubMed ID: 35677499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
    Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
    Front Nutr; 2022; 9():880014. PubMed ID: 35669067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease.
    Xiao J; Lim LKE; Ng CH; Tan DJH; Lim WH; Ho CSH; Tan EXX; Sanyal AJ; Muthiah MD
    Front Med (Lausanne); 2021; 8():691696. PubMed ID: 34277666
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran.
    Moghaddasifar I; Lankarani KB; Moosazadeh M; Afshari M; Ghaemi A; Aliramezany M; Afsar Gharebagh R; Malary M
    Int J Organ Transplant Med; 2016; 7(3):149-160. PubMed ID: 27721961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Pan B; Cai J; Zhao P; Liu J; Fu S; Jing G; Niu Q; Li Q
    Osteoporos Int; 2022 Nov; 33(11):2275-2286. PubMed ID: 35764892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Thongtan T; Deb A; Vutthikraivit W; Laoveeravat P; Mingbunjerdsuk T; Islam S; Islam E
    Indian J Gastroenterol; 2022 Apr; 41(2):119-126. PubMed ID: 35318571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the NAFLD burden in people living with HIV from high- and middle-income nations: a meta-analysis with a data gap from Subsaharan Africa.
    Manzano-Nunez R; Rivera-Esteban J; Navarro J; Bañares J; Sena E; Schattenberg JM; Lazarus JV; Curran A; Pericàs JM
    J Int AIDS Soc; 2023 Mar; 26(3):e26072. PubMed ID: 36924219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.
    Kwon OY; Choi JY; Jang Y
    J Med Internet Res; 2023 Jan; 25():e37487. PubMed ID: 36689264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Lu FB; Zheng KI; Rios RS; Targher G; Byrne CD; Zheng MH
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2041-2050. PubMed ID: 32573017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.